Invisalign (ALGN): Price Target Chart

Corporate company logo of Align Technology Inc (ALGN)

This daily price chart for Align Technology, Inc. (ALGN) is accompanied by ESG data, highlighting the company's implementation of polymer recycling and the minimization of printing defects. The business generates revenue from the sale of orthodontic alignment systems, as well as software and digital scanners for clinics, which constitutes 185.12. Align Technology, Inc. (ALGN) maintains its niche leadership through close ties with orthodontists, despite pressure from new budget competitors.

Invisalign (ALGN) Price Target Chart: for the period 07/04/2022 - 11/11/2026
Core merchandise of Invisalign

The investment attractiveness of Align Technology, Inc. (ALGN) currently depends on its ability to retain the premium segment of the aligner market amid the expansion of low-cost alternatives. This indicator measures the average expected asset value based on the business's ability to pass inflation onto product prices, while the history of analyst targets allows for an assessment of the company's fundamental margin of safety in the face of growing competition.

Competing companies

Analyst Consensus Forecast bostonscientific.com (BSX)|Price Target Chart Edwards Lifesciences Corporation EW|ResMed Inc - Price Target Chart|OmniPod - Analyst Consensus Forecast|Analyst Target Range Zimmer Biomet Corp (ZBH)|The Cooper Companies (COO) - Price Target Chart|Broker Consensus Forecast GMED|Price Target Chart transmedics.com|Alphatec Holdings (ATEC) - Analyst Median Target|Price Target Chart Artivion Inc (AORT)|ENOV: Forecast Levels Chart|Analyst Consensus Forecast IART (Integra LifeSciences)|establishmentlabs.com (ESTA) - Average Forecast Price|Beta Bionics - Analyst Consensus Forecast|IRADIMED Corp (IRMD) - Consensus Target|EMBC: Analyst Consensus Forecast|TNDM - Analyst Median Target|AXGN (AxoGen, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast si-bone.com|Price Target Chart Orthofix (OFIX)|Price Target Chart BVS (Bioventus Inc)|Analyst Consensus Forecast KIDS (OrthoPediatrics)|Analyst Median Target Treace Corp (TMCI)|SRTA: Consensus Target|Forecast Levels Chart CARL|RXST: Analyst Consensus Forecast|Average Forecast Price ClearPoint Neuro (CLPT)|STXS (Stereotaxis Corp) - Analyst Consensus Forecast|Broker Consensus Forecast STIM (Neuronetics, Inc)|Consensus Target SGHT (Sight Sciences, Inc.)|OBIO (Orchestra BioMed Inc.) - Fair Value Consensus|Price Target Chart Anika Therapeutics, Inc. ANIK|NSPR - Consensus Target|Jin Medical International Ltd - Analyst Consensus Forecast|Average Forecast Price Vivani Medical, Inc.|XTNT: Analyst Consensus Forecast|Broker Consensus Forecast NMTC|MODD (Modular Medical Inc) - Analyst Consensus Forecast|Myomo Inc. (MYO) - Analyst Median Target|Analyst Consensus Forecast COCH|Consensus Target Vivos Therapeutics Inc VVOS|Analyst Consensus Forecast NVNO (enVVeno Medical)|Analyst Consensus Forecast Sintx Technologies Inc SINT|TNON - Price Target Chart|LFWD: Price Target Chart|AMIX (autonomix.com) - Consensus Target|INVO Fertility Corp - Fair Value Consensus|BBLG (Bone Biologics) - Analyst Consensus Forecast|Average Forecast Price axonics.com AXNX|Price Target Chart BIOLASE (BIOL)|dynatronics.com (DYNT) - Analyst Target Range|Paragon 28 - Consensus Target|Analyst Consensus Forecast INVO Bioscience Inc. INVO